Web-App Based Physical Activity Program for Depression

N/A

Recruiting

Led By Eun-Ok Im, PhD, MPH

Research Sponsored by University of Texas at Austin

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

who are sedentary (without any disabilities preventing physical activity);

aged 40 to 60 years

Must not have

major signs or symptoms suggestive of pulmonary or CVD

history of a myocardial infarction, stroke, or Type I diabetes mellitus

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline(t0), 6-months post-intervention (t1), and post 12-months post-intervention (t2)

Awards & highlights

No Placebo-Only Group

Summary

This trial is testing the effectiveness of a Web App-based lifestyle physical activity promotion program on depressive symptoms in midlife Korean American women.

Who is the study for?

This trial is for midlife Korean-American women aged 40-60, living in the U.S., who have minimal to moderate depression and are sedentary but can engage in physical activity. Participants must be able to use a computer or mobile device and read/write English or Korean.

What is being tested?

The study tests if a Web App-based Lifestyle Physical Activity Promotion Program can improve depressive symptoms compared to standard CDC guidelines on depression and physical activity for midlife Korean American women.

What are the potential side effects?

Since this trial involves lifestyle changes through a web app, there may not be direct side effects like with medication. However, increasing physical activity could cause muscle soreness or fatigue.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I do not engage in regular physical activity but have no disabilities preventing it.

Select...

I am between 40 and 60 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I show major signs or symptoms of heart or lung disease.

Select...

I have had a heart attack, stroke, or Type I diabetes.

Select...

I am taking beta-blockers, diltiazem, or verapamil.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline(t0), 6-months post-intervention (t1), and post 12-months post-intervention (t2)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline(t0), 6-months post-intervention (t1), and post 12-months post-intervention (t2)

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline(t0), 6-months post-intervention (t1), and post 12-months post-intervention (t2) for reporting.